Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.03% | -27.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.03% | -27.91% | |||
| Cost of Revenue | 70.73% | -5.40% | |||
| Gross Profit | -14.37% | -37.94% | |||
| SG&A Expenses | 14.18% | -2.11% | |||
| Depreciation & Amortization | 38.87% | 5.79% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 34.16% | -2.91% | |||
| Operating Income | -100.29% | -255.63% | |||
| Income Before Tax | -233.41% | -71.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -233.41% | -71.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -233.41% | -71.82% | |||
| EBIT | -100.29% | -255.63% | |||
| EBITDA | -121.96% | -183.14% | |||
| EPS Basic | -233.53% | -71.78% | |||
| Normalized Basic EPS | -201.54% | -71.77% | |||
| EPS Diluted | -233.53% | -71.78% | |||
| Normalized Diluted EPS | -201.54% | -71.77% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||